Extended Use of Botulinum Toxin Type A in Facial Aesthetic Surgery

Aesthetic Surgery Journal

Volumn 18, Issue 3, 1998, Pages 215-219

  Fagien, Steven ^a,b  

^a Collagenesis Inc ^*

^b Dr Fagien is the chairman of the medical advisory board   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0001624063     PISSN: 1090820X     EISSN: 1527330X     Source Type: Journal    
DOI: 10.1016/S1090-820X(98)70043-3     Document Type: Article

References (8)

1. Fagien S. Botulinum toxin A and autologous injectable dermis. Presented at: Annual Meeting of the American Society of Ophthalmic Plastic and Reconstructive Surgery; November 7, 1992, Dallas, TX.
2. Scott A.B., Rosenbaum A., and Collins CC. Pharmacologic weakening of extraocular muscles. Invest Ophthalmol 12 (1973) 924-927
3. Fagien S. Treatment of hyperkinetic facial lines with botulinum toxin. In: Putterman A.M. (Ed). Cosmetic oculoplastic surgery: eyelid, forehead, and facial techniques. 3rd ed (1998), WB Saunders, Philadelphia chap 33
4. Jelks G.W., Glat P.M., Jelks E.B., and Longaker MT. The inferior retinacular lateral canthoplasty: a new technique. Plast Reconstr Surg 100 (1997) 1262-1270
5. Fagien S. Lower eyelid rejuvenation via transconjunctival blepharoplasty and lateral retinacular suspension: a simplified suture canthopexy and algorithm for treatment of the anterior lower eyelid lamella. Oper Tech Plast Reconstr Surg 5 (1998) 1-11
6. Osako M., and Keltner JL. Botulinum A toxin (Oculinum®) in ophthalmology. Survey Ophthalmol 36 (1991) 28-46
7. Klein AW. Cosmetic therapy with botulinum toxin. Dermatol Surg 22 (1996) 757-759
8. Garcia A., and Fulton JE. Cosmetic denervation of the muscles of facial expression with botulinum toxin: a dose-response study. Dermatol Surg 22 (1996) 39-43